相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alcohol use is not a significant contributor to myelodysplastic syndromes
Elizabeth A. Duffy et al.
CANCER CAUSES & CONTROL (2020)
Medical Conditions and Modifiable Risk Factors for Myelodysplastic Syndrome: A Systematic Review
Marina R. Sweeney et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era
Lindsay M. Morton et al.
JAMA ONCOLOGY (2019)
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
Julia Montoro et al.
ANNALS OF HEMATOLOGY (2018)
Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study
Jenny N. Poynter et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience
Su W. Maung et al.
HEMATOLOGY (2017)
Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study
Tomotaka Ugai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Therapy-related myeloid neoplasms: when genetics and environment collide
Megan E. McNerney et al.
NATURE REVIEWS CANCER (2017)
Autoimmune diseases and myelodysplastic syndromes
Rami S. Komrokji et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes
Jenny N. Poynter et al.
CANCER EPIDEMIOLOGY (2016)
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
Erik Hulegardh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Radiotherapy- and Chemotherapy-Induced Myelodysplasia Syndrome A Nationwide Population-Based Nested Case-Control Study
Li-Min Sun et al.
MEDICINE (2015)
Pesticide Exposure as a Risk Factor for Myelodysplastic Syndromes: A Meta-Analysis Based on 1,942 Cases and 5,359 Controls
Jie Jin et al.
PLOS ONE (2014)
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Smita Bhatia
SEMINARS IN ONCOLOGY (2013)
Myelodysplastic Syndrome and Benzene Exposure Among Petroleum Workers: An International Pooled Analysis
A. Robert Schnatter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population
Ling Lv et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006
Anneclaire J. De Roos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort
Xiaomei Ma et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Risks of myeloid malignancies in patients with autoimmune conditions
L. A. Anderson et al.
BRITISH JOURNAL OF CANCER (2009)
Therapy-related myeloid neoplasms
Richard A. Larson
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro)
Tatjana Pekmezovic et al.
ANNALS OF HEMATOLOGY (2006)
Risk factors of myelodysplastic syndromes: a case-control study
SS Strom et al.
LEUKEMIA (2005)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith et al.
BLOOD (2003)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
DH Christiansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Smoking and myelodysplastic syndromes
J Björk et al.
EPIDEMIOLOGY (2000)
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
A Krishnan et al.
BLOOD (2000)
分享论文
